Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117323 · ClinicalTrials.gov registry record
Corneal Opacities in Children
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 54
- Enrollment target
NCT02117323 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 54 participants.
The verdict
NCT02117323 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
A prospective observational study on corneal opacities in infants and children (1 month to 18 years old) will be conducted at CHLA. Most of these cases will be due to congenital corneal opacity (e.g. Peter's anomaly, mucopolysacharidoses) or scarring due to infectious keratitis. Sixty (60) subjects will be recruited. The children will be examined under anesthesia with a portable slit-lamp and OCT. An iVue OCT system (Optovue) attached to an operating microscope-style mount at CHLA will be used for the intraoperative scans. Both cross-sectional and 3-D OCT scans will be performed to assess opacity depth, pachymetry map, endothelial defects, and any abnormal adhesion between the cornea, iris and lens. The anterior chamber angle will also be imaged with cross-sectional OCT to assess angle depth, trabecular meshwork, Schwalbe's line, and possible peripheral iridocorneal adhesion or posterior embryotoxon. OCT of the crystalline lens will be obtained to assess the presence of cataract. Slit-lamp photography will be obtained, and gonioscopy will be performed if indicated. Corneal diameter will be measured with a caliper, and intraocular pressure will be measured with a tonopen (Reichert).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117323
The ClinicalTrials.gov registry entry for NCT02117323 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02117323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117323 about?
NCT02117323 is a clinical study titled "Corneal Opacities in Children". A prospective observational study on corneal opacities in infants and children (1 month to 18 years old) will be conducted at CHLA. Most of these cases will be due to congenital corneal opacity (e.g. Peter's anomaly, mucopolysacharidoses) or scarring due to infectious keratitis. Sixty (60) subjects ...
What is the current status of trial NCT02117323?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2011-09. Estimated completion is 2016-08-31.
Who is sponsoring clinical trial NCT02117323?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.